North America Drugs for Malaria Market by Manufacturers, Countries, Type and Application, Forecast to 2022

Global Info Research
115 Pages
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.


Scope of the Report:
This report focuses on the Drugs for Malaria in North America market, especially in United States, Canada and Mexico. This report categorizes the market based on manufacturers, countries, type and application.

Market Segment by Manufacturers, this report covers
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma

Market Segment by Countries, covering
United States
Canada
Mexico

Market Segment by Type, covers
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds

Market Segment by Applications, can be divided into
Prevention
Treatment
Other

There are 15 Chapters to deeply display the North America Drugs for Malaria market.

Chapter 1, to describe Drugs for Malaria Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force;

Chapter 2, to analyze the manufacturers of Drugs for Malaria, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;

Chapter 4, to show the North America market by countries, covering United States, Canada and Mexico, with sales, revenue and market share of Drugs for Malaria, for each country, from 2012 to 2017;

Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;

Chapter 7, 8 and 9, to analyze the segment market in United States, Canada and Mexico, by manufacturers, type and application, with sales, price, revenue and market share by manufacturers, types and applications;

Chapter 10, Drugs for Malaria market forecast, by countries, type and application, with sales, price and revenue, from 2017 to 2022;

Chapter 11, to analyze the manufacturing cost, key raw materials and manufacturing process etc.

Chapter 12, to analyze the industrial chain, sourcing strategy and downstream end users (buyers);

Chapter 13, to describe sales channel, distributors, traders, dealers etc.

Chapter 14 and 15, to describe Drugs for Malaria Research Findings and Conclusion, Appendix, methodology and data source

Table of Contents
1 Market Overview
1.1 Drugs for Malaria Introduction
1.2 Market Analysis by Type
1.2.1 Aryl Aminoalcohol Compounds
1.2.2 Antifolate Compounds
1.2.3 Artemisinin Compounds
1.3 Market Analysis by Applications
1.3.1 Prevention
1.3.2 Treatment
1.3.3 Other
1.4 Market Analysis by Countries
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 Mexico Status and Prospect (2012-2022)
1.4.3 Canada Status and Prospect (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Cipla
2.1.1 Profile
2.1.2 Drugs for Malaria Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 Cipla News
2.2 Guilin Pharmaceutical
2.2.1 Profile
2.2.2 Drugs for Malaria Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 Guilin Pharmaceutical News
2.3 IPCA Laboratories
2.3.1 Profile
2.3.2 Drugs for Malaria Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 IPCA Laboratories News
2.4 GlaxoSmithKline
2.4.1 Profile
2.4.2 Drugs for Malaria Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 GlaxoSmithKline News
2.5 Mylan Labs
2.5.1 Profile
2.5.2 Drugs for Malaria Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Mylan Labs News
2.6 Roche
2.6.1 Profile
2.6.2 Drugs for Malaria Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6.4 Business Overview
2.6.5 Roche News
2.7 Novartis
2.7.1 Profile
2.7.2 Drugs for Malaria Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7.4 Business Overview
2.7.5 Novartis News
2.8 Sanofi Aventis
2.8.1 Profile
2.8.2 Drugs for Malaria Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8.4 Business Overview
2.8.5 Sanofi Aventis News
2.9 Ajanta Pharma
2.9.1 Profile
2.9.2 Drugs for Malaria Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9.4 Business Overview
2.9.5 Ajanta Pharma News
3 North America Drugs for Malaria Market Competition, by Manufacturer
3.1 North America Drugs for Malaria Sales and Market Share by Manufacturer (2016-2017)
3.2 North America Drugs for Malaria Revenue and Market Share by Manufacturer (2016-2017)
3.3 North America Drugs for Malaria Price by Manufacturers (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Drugs for Malaria Manufacturer Market Share
3.4.2 Top 5 Drugs for Malaria Manufacturer Market Share
3.5 Market Competition Trend
4 North America Drugs for Malaria Market Analysis by Countries
4.1 North America Drugs for Malaria Sales Market Share by Countries
4.2 North America Drugs for Malaria Sales by Countries (2012-2017)
4.3 North America Drugs for Malaria Revenue (Value) by Countries (2012-2017)
5 North America Market Segmentation Drugs for Malaria by Type
5.1 North America Drugs for Malaria Sales, Revenue and Market Share by Type (2012-2017)
5.1.1 North America Drugs for Malaria Sales and Market Share by Type (2012-2017)
5.1.2 North America Drugs for Malaria Revenue and Market Share by Type (2012-2017)
5.2 Aryl Aminoalcohol Compounds Sales Growth and Price
5.2.1 North America Aryl Aminoalcohol Compounds Sales Growth (2012-2017)
5.2.2 North America Aryl Aminoalcohol Compounds Price (2012-2017)
5.3 Antifolate Compounds Sales Growth and Price
5.3.1 North America Antifolate Compounds Sales Growth (2012-2017)
5.3.2 North America Antifolate Compounds Price (2012-2017)
5.4 Artemisinin Compounds Sales Growth and Price
5.4.1 North America Artemisinin Compounds Sales Growth (2012-2017)
5.4.2 North America Artemisinin Compounds Price (2012-2017)
6 North America Market Segmentation Drugs for Malaria by Application
6.1 North America Drugs for Malaria Sales Market Share by Application (2012-2017)
6.2 Prevention Sales Growth (2012-2017)
6.3 Treatment Sales Growth (2012-2017)
6.4 Other Sales Growth (2012-2017)
7 United States Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers
7.1 United States Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)
7.2 United States Drugs for Malaria Sales and Market Share by Type
7.3 United States Drugs for Malaria Sales by Application (2012-2017)
7.4 United States Drugs for Malaria Sales, Revenue and Market Share by Manufacturer
7.4.1 United States Drugs for Malaria Sales and Market Share by Manufacturer
7.4.2 United States Drugs for Malaria Revenue and Market Share by Manufacturer
7.5 United States Drugs for Malaria Export and Import (2012-2017)
8 Canada Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers
8.1 Canada Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)
8.2 Canada Drugs for Malaria Sales and Market Share by Type
8.3 Canada Drugs for Malaria Sales by Application (2012-2017)
8.4 Canada Drugs for Malaria Sales, Revenue and Market Share by Manufacturer
8.4.1 Canada Drugs for Malaria Sales and Market Share by Manufacturer
8.4.2 Canada Drugs for Malaria Revenue and Market Share by Manufacturer
8.5 Canada Drugs for Malaria Export and Import (2012-2017)
9 Mexico Drugs for Malaria Sales, Revenue, by Type, Application and Manufacturers
9.1 Mexico Drugs for Malaria Revenue, Sales and Growth Rate (2012-2017)
9.2 Mexico Drugs for Malaria Sales and Market Share by Type
9.3 Mexico Drugs for Malaria Sales by Application (2012-2017)
9.4 Mexico Drugs for Malaria Sales, Revenue and Market Share by Manufacturer
9.4.1 Mexico Drugs for Malaria Sales and Market Share by Manufacturer
9.4.2 Mexico Drugs for Malaria Revenue and Market Share by Manufacturer
9.5 Mexico Drugs for Malaria Export and Import (2012-2017)
10 Drugs for Malaria Market Forecast (2017-2022)
10.1 North America Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
10.2 Drugs for Malaria Market Forecast by Countries (2017-2022)
10.2.1 United States Drugs for Malaria Forecast (2017-2022)
10.2.2 Canada Drugs for Malaria Forecast (2017-2022)
10.2.3 Mexico Drugs for Malaria Forecast (2017-2022)
10.3 Drugs for Malaria Market Forecast by Type (2017-2022)
10.4 Drugs for Malaria Market Forecast by Application (2017-2022)
11 Drugs for Malaria Manufacturing Cost Analysis
11.1 Drugs for Malaria Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Drugs for Malaria
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Drugs for Malaria Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
12.4 Downstream Buyers
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source


List of Tables and Figures

Figure Drugs for Malaria Picture
Table Product Specifications of Drugs for Malaria
Figure North America Sales Market Share of Drugs for Malaria by Types in 2016
Table Types of Drugs for Malaria
Figure Aryl Aminoalcohol Compounds Picture
Table Major Manufacturers of Aryl Aminoalcohol Compounds
Figure Antifolate Compounds Picture
Table Major Manufacturers of Antifolate Compounds
Figure Artemisinin Compounds Picture
Table Major Manufacturers of Artemisinin Compounds
Table North America Drugs for Malaria Sales Market Share by Applications in 2016
Table Applications of Drugs for Malaria
Figure Prevention Picture
Figure Treatment Picture
Figure Other Picture
Figure United States Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Mexico Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Canada Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Drugs for Malaria Type and Applications
Table Cipla Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Guilin Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Guilin Pharmaceutical Drugs for Malaria Type and Applications
Table Guilin Pharmaceutical Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table IPCA Laboratories Basic Information, Manufacturing Base and Competitors
Table IPCA Laboratories Drugs for Malaria Type and Applications
Table IPCA Laboratories Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table GlaxoSmithKline Drugs for Malaria Type and Applications
Table GlaxoSmithKline Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Mylan Labs Basic Information, Manufacturing Base and Competitors
Table Mylan Labs Drugs for Malaria Type and Applications
Table Mylan Labs Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Drugs for Malaria Type and Applications
Table Roche Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Drugs for Malaria Type and Applications
Table Novartis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi Aventis Drugs for Malaria Type and Applications
Table Sanofi Aventis Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table Ajanta Pharma Drugs for Malaria Type and Applications
Table Ajanta Pharma Drugs for Malaria Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table North America Drugs for Malaria Sales by Manufacturer (2016-2017)
Figure North America Drugs for Malaria Sales Market Share by Manufacturer in 2016
Figure North America Drugs for Malaria Sales Market Share by Manufacturer in 2017
Table North America Drugs for Malaria Revenue by Manufacturer (2016-2017)
Figure North America Drugs for Malaria Revenue Market Share by Manufacturer in 2016
Figure North America Drugs for Malaria Revenue Market Share by Manufacturer in 2017
Table North America Drugs for Malaria Price by Manufacturers (2016-2017)
Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2016
Figure Top 3 Drugs for Malaria Manufacturer Market Share in 2017
Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2016
Figure Top 5 Drugs for Malaria Manufacturer Market Share in 2017
Figure North America Drugs for Malaria Sales and Growth (2012-2017)
Table North America Drugs for Malaria Sales by Countries (2012-2017)
Table North America Drugs for Malaria Sales Market Share by Countries (2012-2017)
Figure North America 2012 Drugs for Malaria Sales Market Share by Countries
Figure North America 2016 Drugs for Malaria Sales Market Share by Countries
Figure North America Drugs for Malaria Revenue and Growth (2012-2017)
Table North America Drugs for Malaria Revenue by Countries (2012-2017)
Table North America Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Table North America 2012 Drugs for Malaria Revenue Market Share by Countries
Table North America 2016 Drugs for Malaria Revenue Market Share by Countries
Table North America Drugs for Malaria Sales by Type (2012-2017)
Table North America Drugs for Malaria Sales Share by Type (2012-2017)
Table North America Drugs for Malaria Revenue by Type (2012-2017)
Table North America Drugs for Malaria Revenue Share by Type (2012-2017)
Figure North America Aryl Aminoalcohol Compounds Sales Growth (2012-2017)
Figure North America Aryl Aminoalcohol Compounds Price (2012-2017)
Figure North America Antifolate Compounds Sales Growth (2012-2017)
Figure North America Antifolate Compounds Price (2012-2017)
Figure North America Artemisinin Compounds Sales Growth (2012-2017)
Figure North America Artemisinin Compounds Price (2012-2017)
Table North America Drugs for Malaria Sales by Application (2012-2017)
Table North America Drugs for Malaria Sales Share by Application (2012-2017)
Figure North America Prevention Sales Growth (2012-2017)
Figure North America Treatment Sales Growth (2012-2017)
Figure North America Other Sales Growth (2012-2017)
Figure United States Drugs for Malaria Revenue and Growth (2012-2017)
Figure United States Drugs for Malaria Sales and Growth (2012-2017)
Table United States Drugs for Malaria Sales by Type (2012-2017)
Table United States Drugs for Malaria Sales Market Share by Type (2012-2017)
Table United States Drugs for Malaria Sales by Application (2012-2017)
Table United States Drugs for Malaria Sales Market Share by Application (2012-2017)
Table United States Drugs for Malaria Sales by Manufacturer (2016-2017)
Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2016
Figure United States Drugs for Malaria Sales Market Share by Manufacturer in 2017
Table United States Drugs for Malaria Revenue by Manufacturer (2016-2017)
Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2016
Figure United States Drugs for Malaria Revenue Market Share by Manufacturer in 2017
Table United States Drugs for Malaria Export and Import (2012-2017)
Figure Canada Drugs for Malaria Revenue and Growth (2012-2017)
Figure Canada Drugs for Malaria Sales and Growth (2012-2017)
Table Canada Drugs for Malaria Sales by Type (2012-2017)
Table Canada Drugs for Malaria Sales Market Share by Type (2012-2017)
Table Canada Drugs for Malaria Sales by Application (2012-2017)
Table Canada Drugs for Malaria Sales Market Share by Application (2012-2017)
Table Canada Drugs for Malaria Sales by Manufacturer (2016-2017)
Figure Canada Drugs for Malaria Sales Market Share by Manufacturer in 2016
Figure Canada Drugs for Malaria Sales Market Share by Manufacturer in 2017
Table Canada Drugs for Malaria Revenue by Manufacturer (2016-2017)
Figure Canada Drugs for Malaria Revenue Market Share by Manufacturer in 2016
Figure Canada Drugs for Malaria Revenue Market Share by Manufacturer in 2017
Table Canada Drugs for Malaria Export and Import (2012-2017)
Figure Mexico Drugs for Malaria Revenue and Growth (2012-2017)
Figure Mexico Drugs for Malaria Sales and Growth (2012-2017)
Table Mexico Drugs for Malaria Sales by Type (2012-2017)
Table Mexico Drugs for Malaria Sales Market Share by Type (2012-2017)
Table Mexico Drugs for Malaria Sales by Application (2012-2017)
Table Mexico Drugs for Malaria Sales Market Share by Application (2012-2017)
Table Mexico Drugs for Malaria Sales by Manufacturer (2016-2017)
Figure Mexico Drugs for Malaria Sales Market Share by Manufacturer in 2016
Figure Mexico Drugs for Malaria Sales Market Share by Manufacturer in 2017
Table Mexico Drugs for Malaria Revenue by Manufacturer (2016-2017)
Figure Mexico Drugs for Malaria Revenue Market Share by Manufacturer in 2016
Figure Mexico Drugs for Malaria Revenue Market Share by Manufacturer in 2017
Table Mexico Drugs for Malaria Export and Import (2012-2017)
Figure North America Drugs for Malaria Sales, Revenue and Growth Rate (2017-2022)
Table North America Drugs for Malaria Sales Forecast by Countries (2017-2022)
Table North America Drugs for Malaria Market Share Forecast by Countries (2017-2022)
Figure United States Drugs for Malaria Sales Forecast (2017-2022)
Figure Canada Drugs for Malaria Sales Forecast (2017-2022)
Figure Mexico Drugs for Malaria Sales Forecast (2017-2022)
Table North America Drugs for Malaria Sales Forecast by Type (2017-2022)
Table North America Drugs for Malaria Market Share Forecast by Type (2017-2022)
Table North America Drugs for Malaria Sales Forecast by Application (2017-2022)
Table North America Drugs for Malaria Market Share Forecast by Application (2017-2022)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Malaria
Figure Manufacturing Process Analysis of Drugs for Malaria
Figure Drugs for Malaria Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
Table Major Buyers of Drugs for Malaria
Table Distributors/Traders/ Dealers List

captcha Cheak Discount
 
Can't read the image? click here to refresh
* mark fields are compulsory

Asia-Pacific Tattoo Needles Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-09-20 Pharma & Healthcare

Tattooing is quite a favorite choice for a large number of people today. The tattoo parlors are also...Read More

Asia-Pacific Phenylketonuria (PKU) Market by Manufacturers, Regions, Type and Application, Forecast to 2022

GIR 2017-09-20 Pharma & Healthcare

This report studies the Phenylketonuria (PKU) market. Phenylketonuria (PKU) is an inborn error of me...Read More

United States Prostaglandin Market by Manufacturers, States, Type and Application, Forecast to 2022

GIR 2017-09-20 Pharma & Healthcare

"This report studies the Prostaglandin market. Prostaglandins are autocank derived from arachidonic ...Read More

Report's License Type

$4480
$8960

Related Keywords

If you are facing any issues while making the payment, you can contact us on

+1-888-376-9998
sales@globalinforeports.com

We will be happy to assist you.